JP2024502174A5 - - Google Patents

Info

Publication number
JP2024502174A5
JP2024502174A5 JP2023541657A JP2023541657A JP2024502174A5 JP 2024502174 A5 JP2024502174 A5 JP 2024502174A5 JP 2023541657 A JP2023541657 A JP 2023541657A JP 2023541657 A JP2023541657 A JP 2023541657A JP 2024502174 A5 JP2024502174 A5 JP 2024502174A5
Authority
JP
Japan
Prior art keywords
alkyl
groups
alkylene
haloalkyl
heterocycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023541657A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024502174A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2022/050014 external-priority patent/WO2022147620A1/en
Publication of JP2024502174A publication Critical patent/JP2024502174A/ja
Publication of JP2024502174A5 publication Critical patent/JP2024502174A5/ja
Pending legal-status Critical Current

Links

JP2023541657A 2021-01-07 2022-01-07 Nuakキナーゼの阻害剤としてのチエニル及びシクロアルキルアミノピリミジン化合物、その組成物及び使用 Pending JP2024502174A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163134739P 2021-01-07 2021-01-07
US63/134,739 2021-01-07
PCT/CA2022/050014 WO2022147620A1 (en) 2021-01-07 2022-01-07 Thienyl and cycloalkyl aminopyrimidine compounds as inhibitors of nuak kinases, compositions and uses thereof

Publications (2)

Publication Number Publication Date
JP2024502174A JP2024502174A (ja) 2024-01-17
JP2024502174A5 true JP2024502174A5 (cg-RX-API-DMAC7.html) 2024-12-10

Family

ID=82356983

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023541657A Pending JP2024502174A (ja) 2021-01-07 2022-01-07 Nuakキナーゼの阻害剤としてのチエニル及びシクロアルキルアミノピリミジン化合物、その組成物及び使用

Country Status (7)

Country Link
US (1) US20240025887A1 (cg-RX-API-DMAC7.html)
EP (1) EP4274829A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024502174A (cg-RX-API-DMAC7.html)
CN (1) CN116981664A (cg-RX-API-DMAC7.html)
AU (1) AU2022205713A1 (cg-RX-API-DMAC7.html)
CA (1) CA3204383A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022147620A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116903592B (zh) * 2023-07-13 2025-08-01 特科罗生物科技(成都)有限公司 一种嘧啶胺类nuak抑制剂及其制备方法和用途
CN116947764B9 (zh) * 2023-07-13 2025-07-25 特科罗生物科技(成都)有限公司 一种嘧啶胺类nuak抑制剂及其制备方法和用途
CN116903591B (zh) * 2023-07-13 2025-08-26 特科罗生物科技(成都)有限公司 一种嘧啶胺类nuak抑制剂及其制备方法和用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4812763B2 (ja) * 2004-05-18 2011-11-09 ライジェル ファーマシューティカルズ, インコーポレイテッド シクロアルキル置換ピリミジンジアミン化合物およびそれらの用途
JP2008540436A (ja) * 2005-05-03 2008-11-20 ライジェル ファーマシューティカルズ, インコーポレイテッド Jakキナーゼインヒビターおよびそれらの使用
EP1966207A2 (en) * 2005-12-21 2008-09-10 Pfizer Products Inc. Pyrimidine derivatives for the treatment of abnormal cell growth
EP2007754A1 (en) * 2006-04-10 2008-12-31 Boehringer Ingelheim International GmbH 2, 4-diaminopyrimidine derivatives and their use for the treatment of cancer
MX2009004426A (es) * 2006-10-23 2009-08-12 Cephalon Inc Derivados biciclicos fusionados de 2,4-diaminopirimidina como inhibidores alk y c-met.
EP2109605B1 (en) * 2006-12-22 2013-02-20 Boehringer Ingelheim International GmbH 2- [(phenylamino) -pyrimidin-4ylamin0] -cyclopentane carboxamide derivatives and related compounds as inhibitors of kinases of the cell cycle for the treatment of cancer
BRPI0815979A2 (pt) * 2007-08-28 2017-06-13 Irm Llc compostos e composições com inibidores de quinase, bem como uso dos mesmos
JP2011523646A (ja) * 2008-05-21 2011-08-18 アリアド・ファーマシューティカルズ・インコーポレイテッド キナーゼ阻害剤としてのリン誘導体
KR20130139999A (ko) * 2010-10-14 2013-12-23 어리어드 파마슈티칼스, 인코포레이티드 Egfr-유도된 암의 세포 증식을 억제하는 방법
CN110724137B (zh) * 2019-11-13 2021-03-30 广东工业大学 一种噻吩类衍生物及其制备方法与应用

Similar Documents

Publication Publication Date Title
JP2024502175A5 (cg-RX-API-DMAC7.html)
JP2023542541A5 (cg-RX-API-DMAC7.html)
RU2477723C2 (ru) Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе
RU2472797C2 (ru) ПРОИЗВОДНЫЕ 2-[(2-(ФЕНИЛАМИНО)-1Н-ПИРРОЛО[2,3-d]ПИРИМИДИН-4-ИЛ)АМИНО]БЕНЗАМИДА В КАЧЕСТВЕ ИНГИБИТОРОВ IGF-1R ДЛЯ ЛЕЧЕНИЯ РАКА
JP2020536069A5 (cg-RX-API-DMAC7.html)
JP2017528498A5 (cg-RX-API-DMAC7.html)
JP2025081607A (ja) 統合的ストレス経路のプロドラッグ調節剤
US10414734B2 (en) 5-hydroxyalkylbenzimidazoles as mIDH1 inhibitors
PE20220133A1 (es) Inhibidores del inflamasoma nlrp3
JP2024530952A5 (cg-RX-API-DMAC7.html)
HRP20150489T1 (hr) Imidazo[4,5-c]kinolini kao inhibitori dna-pk
JP2017519754A5 (cg-RX-API-DMAC7.html)
RU2015149528A (ru) 2-фенилимидазо[1,2-а]пиримидины в качестве визуализирующих средств
JP2013544893A5 (cg-RX-API-DMAC7.html)
JP2013538801A5 (cg-RX-API-DMAC7.html)
HRP20141094T1 (hr) 1,2,5-oksadiazoli kao inhibitori indolamin 2,3-dioksigenaze
JP2017504576A5 (cg-RX-API-DMAC7.html)
JP5149177B2 (ja) 増殖性疾患の治療のための、チューブリンポリマー化の1,2,3−トリアゾール系抑制剤
HRP20171037T1 (hr) Inhibitori neprilizina
JP2014518543A5 (cg-RX-API-DMAC7.html)
KR101063462B1 (ko) 아릴 및 헤테로아릴 프로펜 아미드, 이들의 유도체 및 이의치료학적 용도
KR20140060466A (ko) 진단적 영상화를 위한 방사성표지된 아미노산
JP2024534840A5 (cg-RX-API-DMAC7.html)
JP2022550353A5 (cg-RX-API-DMAC7.html)
JP2017538697A5 (cg-RX-API-DMAC7.html)